No takes yet. Share an insight, caveat, or question.
Review highlights novel drug targets, repurposed agents, and host-directed therapies for resistant tuberculosis, suggesting strategies to meet global End-TB targets.
Ashaolu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: